HeartSciences (HSCSW) Cash from Financing Activities (2022 - 2026)
HeartSciences' (HSCSW) quarterly Cash from Financing Activities came in at -$63673.0 in Q2 2026, down 163.66% on a YoY basis from $100028.0 in Q2 2025, and down 104.22% quarter-over-quarter from $1.5 million in Q4 2025.
Powered by 
Analysis
HeartSciences (HSCSW) Cash from Financing Activities (2022 - 2026) Analysis & Trends
HeartSciences (HSCSW) has reported Cash from Financing Activities for 5 consecutive years, with -$63673.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 163.66% year-over-year to -$63673.0; the trailing twelve-month figure through Apr 2026 stood at $5.2 million (up 89.99% YoY), and the FY2026 full-year result was $8.0 million, up 193.74% from the prior year.
- Cash from Financing Activities eased to -$63673.0 in Q2 2026 per HSCSW's latest filing, from $1.5 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $9.1 million in Q1 2024 and bottomed at -$121522.0 in Q1 2023.
- Historically, Cash from Financing Activities has averaged $1.6 million across 5 years, with a median of $551683.0 in 2024.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities surged 7610.17% in 2024, then tumbled 163.66% in 2026.
- Over 5 years, Cash from Financing Activities stood at -$116392.0 in 2022, then jumped by 542.15% to $514629.0 in 2023, then jumped by 269.53% to $1.9 million in 2024, then decreased by 20.66% to $1.5 million in 2025, then sank by 104.22% to -$63673.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$63673.0, $1.5 million, and $3.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.82 Bn | 27.71 Bn | 2.18 Bn | -236.00 Mn |
| 2 | Lantheus Holdings | 6.58 Bn | 5.98 Bn | 241.86 Mn | 4.51 Mn |
| 3 | Heartflow | 4.13 Bn | 3.76 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.57 Bn | 2.39 Bn | 107.80 Mn | -300,000.00 |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | 3.95 Mn |
| 6 | Ceribell | 927.22 Mn | 797.96 Mn | 25.94 Mn | 880,000.00 |
| 7 | QuidelOrtho | 880.39 Mn | 756.99 Mn | - | 200.60 Mn |
| 8 | Varex Imaging | 778.85 Mn | 679.65 Mn | 76.70 Mn | -1.20 Mn |
| 9 | Prenetics Global | 339.43 Mn | 280.38 Mn | 30.20 Mn | -22.86 Mn |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - | -63,673.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -63,673.00 |
| Oct 31, 2025 | 1.51 Mn |
| Jul 31, 2025 | 3.65 Mn |
| Apr 30, 2025 | 100,028.00 |
| Jan 31, 2025 | 180,187.00 |
| Oct 31, 2024 | 1.90 Mn |
| Jul 31, 2024 | 551,683.00 |
| Apr 30, 2024 | 377,142.00 |
| Jan 31, 2024 | 9.13 Mn |
| Oct 31, 2023 | 514,629.00 |
| Jul 31, 2023 | 324,362.00 |
| Apr 30, 2023 | 1.60 Mn |
| Jan 31, 2023 | -121,522.00 |
| Oct 31, 2022 | -116,392.00 |
| Jul 31, 2022 | 5.17 Mn |
| Apr 30, 2022 | 782,374.00 |
| Jan 31, 2022 | 1.92 Mn |